Rheumatoid Arthritis
Overview
- Ultrasound and MRI in the Early Diagnosis of Joint Damage in RA
- Update on Surgery in Arthritis Disorders: Interview with Experts
- Ethical Issues in Rheumatology
- Rheumatoid Arthritis - Board Review
- Pregnancy in Autoimmune and Musculoskeletal Disease
- Cytokines in Inflammatory Disease
- Ethics in Rheumatology
- An In-Depth Topic Review of Rheumatoid Arthritis
- Update on Smallpox and Flu Vaccinations
- Biologics: Adalimumab Joins the Anti-TNF Line-Up
Diagnosis
Therapy/Surgery
- How do patients respond to support groups such as those at HSS for lupus, rheumatoid arthritis, and myositis? Do patients with mild disease get upset seeing the severe cases?
- Disparities in Treatment: A Decision Sciences Perspective
- Pulmonary Nodules in an Infliximab-Treated Rheumatoid Arthritis Patient
- RA Therapeutics - Board Review
- Combination Therapy in Rheumatoid Arthritis
- Rheumatoid Arthritis - Combination Therapy
- Gene Therapy in Rheumatoid Arthritis
- A Call to Arms: Treat Rheumatologic Disorders Early and Effectively with Disease-modifying Therapy
- Which treatments worsen rheumatoid nodules, and which makes them resolve?
- The History, Basic Science and Biology of TNF
- Lower the Thermostat - the Heat is Too High: Winning the Battle and the War
- Rituximab in the treatment of rheumatoid arthritis, systemic lupus, and other autoimmune diseases: past, present, and future
- Would a history of optic neuritis be considered a contraindication for TNF-alpha inhibitor therapy? In the few cases of MS-type symptoms in patients on these therapies, have the symptoms reversed when the medications were discontinued?
- Postmarketing Adverse Event Data for TNF-alpha Antagonists
- TNF-alpha Inhibitors and Lymphoma: More Data Needed to Assess Risk
- Quality of Life Benefits for TNF-Blockers vs. DMARDs
- Our Amazing Progress - and More Within Rheumatology's Grasp
- In RA patients unresponsive to several DMARDs but who are PPD+ although the chest X-ray is negative, how long should INH prophylaxis be maintained before initiating an anti-TNF agent? Is anakinra safe to use in patients with a positive PPD?
- Doxycycline added to MTX in Early Seropositive RA: Improved Benefits vs. MTX Alone
- Can tight control of early RA with a DAS target yield significantly better outcomes?
Complications & Secondary Illness
- Rheumatoid Arthritis: Systemic Disorder with Major Collateral Damage - Board Review
- What has been the experience with anti-TNF agents during pregnancy? Should they be discontinued prior to pregnancy and, if so, how far ahead of a planned pregnancy?
- Is methotrexate contraindicated in rheumatoid arthritis patients who have evidence of hepatitis B or C?What options are available for such patients if biologic agents are financially out of reach?
- In patients with rheumatoid arthritis who have evidence of hepatitis B or C infection, can TNF-a antagonists or IL-1 antagonists be safely used?
- Can TNF inhibitors be used in HIV-positive patients?
Research
- Is There a Role for NFAT Inhibitors in the Prevention of Bone Destruction?
- Disparities in Treatment: A Decision Sciences Perspective
- The Clinical and Immunological Personality of Rheumatoid Arthritis: An Interview with Experts
- Imaging of Juvenile Rheumatoid Arthritis
- HSS Manual Ch. 5 - Immunogenetic Aspects Of Rheumatic Diseases
Clinical Trials
Related Conditions/Issues
Development of Condition
Treatments
- CPC: Pulmonary Nodules in an Infliximab-Treated Rheumatoid Arthritis Patient
- Two New Biologic Agents for Rheumatoid Arthritis: Rituximab (Rituxan) and Abatacept (Orencia)
- RA Therapeutics - Board Review
- About the Surgical Arthritis Service at Hospital for Special Surgery
- Combination Therapy in Rheumatoid Arthritis
- Rheumatoid Arthritis - Combination Therapy
- Gene Therapy in Rheumatoid Arthritis
- Rheumatoid Arthritis: Systemic Disorder with Major Collateral Damage - Board Review
- Medical Management of Arthritis: Early Diagnosis and Current Therapies
- Perioperative Management of Medications Used in the Treatment of Rheumatoid Arthritis
- Special Report: Pfizer releases data raising question about cardiac safety of celecoxib (Celebrex)
- Bextra® Withdrawal from the Market - HSS Physicians Reflect on Options for Patients in Pain
- Combination Therapy for Rheumatoid Arthritis in the Era of Biologicals
- Contact HSS
- Give to HSS
- Maps and Directions
- Notice of Privacy Practices
- Terms of Use
- Joint Commission Notice
- HSS Staff Login
©2009 Hospital for Special Surgery. 535 East 70th Street, New York, NY 10021
